Clorox (CLX) Expected to Post Quarterly Earnings on Monday

Clorox (NYSE:CLX) is expected to release its Q4 2026 results after the market closes on Monday, August 3rd. Analysts expect Clorox to post earnings of $1.64 per share and revenue of $1.9143 billion for the quarter. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Interested persons may review the information on the company’s upcoming Q4 2026 earning report page for the latest details on the call scheduled for Monday, August 3, 2026 at 5:00 PM ET.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the business posted $1.45 earnings per share. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. On average, analysts expect Clorox to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Clorox Price Performance

Shares of NYSE CLX opened at $95.61 on Monday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. Clorox has a fifty-two week low of $84.70 and a fifty-two week high of $131.86. The business has a 50 day moving average price of $95.10 and a two-hundred day moving average price of $103.85. The firm has a market cap of $11.56 billion, a PE ratio of 15.52 and a beta of 0.54.

Analyst Ratings Changes

Several research firms have recently commented on CLX. Wells Fargo & Company reduced their target price on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research note on Monday, May 18th. Jefferies Financial Group dropped their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research note on Monday, May 4th. JPMorgan Chase & Co. cut their price target on shares of Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a report on Thursday, July 16th. Royal Bank Of Canada decreased their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. Finally, Morgan Stanley dropped their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $102.80.

Insider Activity at Clorox

In other news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.63% of the company’s stock.

Hedge Funds Weigh In On Clorox

A number of hedge funds have recently added to or reduced their stakes in CLX. Strive Financial Group LLC bought a new stake in Clorox during the fourth quarter valued at $170,000. Sittner & Nelson LLC lifted its position in shares of Clorox by 44.9% in the 3rd quarter. Sittner & Nelson LLC now owns 971 shares of the company’s stock worth $120,000 after buying an additional 301 shares during the last quarter. EFG International AG acquired a new position in shares of Clorox in the 4th quarter valued at about $108,000. Kelleher Financial Advisors acquired a new position in shares of Clorox in the 3rd quarter valued at about $76,000. Finally, Triumph Capital Management grew its position in shares of Clorox by 295.7% during the 4th quarter. Triumph Capital Management now owns 645 shares of the company’s stock valued at $65,000 after buying an additional 482 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.